Your browser doesn't support javascript.
loading
Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers.
Carlier, Patrick; Markarian, Maritza; Bernard, Nathalie; Lagarce, Laurence; Dautriche, Anne; Béné, Johana; Fouilhé Sam-Lai, Nathalie; Eftekhari, Pirayeh.
Affiliation
  • Carlier P; Centre régional de Pharmacovigilance, Hôpital Fernand-Widal,AP-HP, Paris, France. pharmacovigilance.fwd.lrb@aphp.fr.
  • Bernard N; Centre régional de Pharmacovigilance, Hospices Civils de Lyon, Lyon, France.
  • Lagarce L; Centre régional de Pharmacovigilance, CHRU Angers, Angers, France.
  • Dautriche A; Centre régional de Pharmacovigilance, CHU Dijon, Dijon, France.
  • Béné J; Centre régional de Pharmacovigilance du Nord Pas de Calais, CHU Lille, 59000, Lille, France.
  • Fouilhé Sam-Lai N; Centre régional de Pharmacovigilance, CHU Grenoble Alpes, Grenoble, France.
  • Eftekhari P; Centre régional de Pharmacovigilance, Hôpital Fernand-Widal,AP-HP, Paris, France.
Arch Gynecol Obstet ; 295(2): 269-271, 2017 02.
Article in En | MEDLINE | ID: mdl-27942835
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Arch Gynecol Obstet Journal subject: GINECOLOGIA / OBSTETRICIA Year: 2017 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Arch Gynecol Obstet Journal subject: GINECOLOGIA / OBSTETRICIA Year: 2017 Type: Article Affiliation country: France